Wilson's disease with cognitive impairment and without extrapyramidal signs: improvement of neuropsychological performance and reduction of MRI abnormalities with trientine treatment.

Abstract

Extrapyramidal signs are neurological dysfunction commonly associated with Wilson's disease (WD). In addition, cognitive dysfunction has been reported in the early stages of WD. In this report, we describe a 49-year-old woman presenting with memory impairments and without Parkinsonian or extrapyramidal signs. She was diagnosed with WD based on the presence of Kayser-Fleischer rings around the irises of her eyes and two ATP7B gene mutations, R778L at exon 8 and A874V at exdyon 11. Serial magnetic resonance imaging analysis and neuropsychological tests showed improvements following treatment with trientine.

• Authors: Eun Joo Chung, Eung Gyu Kim, Sang Jin Kim, Ki-Hwan Ji, Jung Hwa Seo
• Journal: Neurocase (Neurocase) Vol. 22 Issue 1 Pg. 40-4 ( 2016) ISSN: 1465-3656 [Electronic] England
• PMID: 25988284 (Publication Type: Case Reports, Journal Article)

Chemical References

• Chelating Agents
• Trientine

Topics

• Brain (drug effects, pathology)
• Chelating Agents (pharmacology, therapeutic use)
• Cognition Disorders (complications, drug therapy, pathology)
• Female
• Hepatolenticular Degeneration (complications, drug therapy, pathology)
• Humans
• Magnetic Resonance Imaging
• Middle Aged
• Neuropsychological Tests
• Treatment Outcome
• Trientine (pharmacology, therapeutic use)